• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病诱导的代谢物改变对视网膜神经退行性变的影响。

Implications of Diabetes-Induced Altered Metabolites on Retinal Neurodegeneration.

作者信息

Aldosari Dalia I, Malik Ajamaluddin, Alhomida Abdullah S, Ola Mohammad S

机构信息

Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.

出版信息

Front Neurosci. 2022 Jul 13;16:938029. doi: 10.3389/fnins.2022.938029. eCollection 2022.

DOI:10.3389/fnins.2022.938029
PMID:35911994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9328693/
Abstract

Diabetic retinopathy (DR) is one of the major complications of diabetic eye diseases, causing vision loss and blindness worldwide. The concept of diabetic retinopathy has evolved from microvascular disease into more complex neurovascular disorders. Early in the disease progression of diabetes, the neuronal and glial cells are compromised before any microvascular abnormalities clinically detected by the ophthalmoscopic examination. This implies understanding the pathophysiological mechanisms at the early stage of disease progression especially due to diabetes-induced metabolic alterations to damage the neural retina so that early intervention and treatments options can be identified to prevent and inhibit the progression of DR. Hyperglycemia has been widely considered the major contributor to the progression of the retinal damage, even though tight control of glucose does not seem to have a bigger effect on the incidence or progression of retinal damage that leads to DR. Emerging evidence suggests that besides diabetes-induced hyperglycemia, dyslipidemia and amino acid defects might be a major contributor to the progression of early neurovascular retinal damage. In this review, we have discussed recent advances in the alterations of key metabolites of carbohydrate, lipid, and amino acids and their implications for neurovascular damage in DR.

摘要

糖尿病视网膜病变(DR)是糖尿病眼部疾病的主要并发症之一,在全球范围内导致视力丧失和失明。糖尿病视网膜病变的概念已从微血管疾病演变为更复杂的神经血管疾病。在糖尿病疾病进展的早期,在通过眼底镜检查临床检测到任何微血管异常之前,神经元和神经胶质细胞就已受损。这意味着要了解疾病进展早期的病理生理机制,特别是由于糖尿病引起的代谢改变对神经视网膜的损害,以便能够确定早期干预措施和治疗方案,以预防和抑制DR的进展。高血糖一直被广泛认为是视网膜损伤进展的主要因素,尽管严格控制血糖似乎对导致DR的视网膜损伤的发生率或进展没有更大影响。新出现的证据表明,除了糖尿病引起的高血糖外,血脂异常和氨基酸缺陷可能是早期神经血管性视网膜损伤进展的主要因素。在这篇综述中,我们讨论了碳水化合物、脂质和氨基酸关键代谢物变化的最新进展及其对DR中神经血管损伤的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7d/9328693/5a5c4dcfc977/fnins-16-938029-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7d/9328693/1a5a8b330316/fnins-16-938029-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7d/9328693/52ce8862ab90/fnins-16-938029-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7d/9328693/fa39b3c6e2c0/fnins-16-938029-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7d/9328693/5a5c4dcfc977/fnins-16-938029-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7d/9328693/1a5a8b330316/fnins-16-938029-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7d/9328693/52ce8862ab90/fnins-16-938029-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7d/9328693/fa39b3c6e2c0/fnins-16-938029-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d7d/9328693/5a5c4dcfc977/fnins-16-938029-g0004.jpg

相似文献

1
Implications of Diabetes-Induced Altered Metabolites on Retinal Neurodegeneration.糖尿病诱导的代谢物改变对视网膜神经退行性变的影响。
Front Neurosci. 2022 Jul 13;16:938029. doi: 10.3389/fnins.2022.938029. eCollection 2022.
2
Neurodegeneration and neuroprotection in diabetic retinopathy.糖尿病性视网膜病变中的神经变性与神经保护。
Int J Mol Sci. 2013 Jan 28;14(2):2559-72. doi: 10.3390/ijms14022559.
3
Retinal Cell Damage in Diabetic Retinopathy.糖尿病性视网膜病变中的视网膜细胞损伤。
Cells. 2023 May 8;12(9):1342. doi: 10.3390/cells12091342.
4
Retinal Neurodegeneration in Diabetes: an Emerging Concept in Diabetic Retinopathy.糖尿病性视网膜病变中视网膜神经退行性变:一个新兴概念。
Curr Diab Rep. 2021 Dec 13;21(12):65. doi: 10.1007/s11892-021-01428-x.
5
Neurodegeneration in diabetic retina and its potential drug targets.糖尿病视网膜神经退行性变及其潜在的药物靶点。
Curr Neuropharmacol. 2014 Jul;12(4):380-6. doi: 10.2174/1570159X12666140619205024.
6
Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.糖尿病视网膜病变中的神经血管相互作用:病理生理作用及治疗意义
Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H738-49. doi: 10.1152/ajpheart.00005.2016. Epub 2016 Jul 29.
7
Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets.糖尿病视网膜病变中的神经血管单元:病理生理作用及潜在治疗靶点
Eye Vis (Lond). 2021 May 1;8(1):15. doi: 10.1186/s40662-021-00239-1.
8
[The state of ocular neurosensory apparatus in diabetes mellitus].[糖尿病患者眼部神经感觉器官的状态]
Vestn Oftalmol. 2018;134(5. Vyp. 2):263-269. doi: 10.17116/oftalma2018134051263.
9
Diabetic Retinopathy: The Role of Mitochondria in the Neural Retina and Microvascular Disease.糖尿病视网膜病变:线粒体在神经视网膜和微血管疾病中的作用
Antioxidants (Basel). 2020 Sep 23;9(10):905. doi: 10.3390/antiox9100905.
10
Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.神经视网膜中 Glut1 的减少而非 RPE 可减轻多元醇的积累并使糖尿病视网膜病变的早期特征正常化。
J Neurosci. 2021 Apr 7;41(14):3275-3299. doi: 10.1523/JNEUROSCI.2010-20.2021. Epub 2021 Feb 23.

引用本文的文献

1
Efficacy and Safety of Qiming Granule for Nerve Injury Associated with Non-proliferative Diabetic Retinopathy: A Multicenter, Randomized, Non-inferiority, Active-Controlled Clinical Trial.芪明颗粒治疗非增殖性糖尿病视网膜病变相关神经损伤的有效性和安全性:一项多中心、随机、非劣效、阳性对照临床试验
Chin J Integr Med. 2025 May 15. doi: 10.1007/s11655-025-3822-0.
2
Retinal Pigment Epithelium Specific Metabolic Phenotypes Are Regulated by High-Mobility Group Protein N1.视网膜色素上皮特异性代谢表型受高迁移率族蛋白N1调控。
Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):70. doi: 10.1167/iovs.66.4.70.
3
Natural remedies proposed for the management of diabetic retinopathy (DR): diabetic complications.

本文引用的文献

1
Plasma Metabolomics Reveals Metabolic Profiling For Diabetic Retinopathy and Disease Progression.血浆代谢组学揭示糖尿病视网膜病变及疾病进展的代谢特征。
Front Endocrinol (Lausanne). 2021 Oct 29;12:757088. doi: 10.3389/fendo.2021.757088. eCollection 2021.
2
A Clinical Conundrum: Intensifying Glycemic Control in the Presence of Advanced Diabetic Retinopathy.一个临床难题:在存在晚期糖尿病视网膜病变的情况下强化血糖控制。
Diabetes Care. 2021 Sep 21;44(10):2192-3. doi: 10.2337/dci21-0029.
3
Metabolomics in Diabetic Retinopathy: A Systematic Review.
用于治疗糖尿病视网膜病变(DR)的天然疗法:糖尿病并发症。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 15. doi: 10.1007/s00210-025-03866-w.
4
Identification and mechanistic analysis of neurovascular coupling related biomarkers for diabetic macular edema.糖尿病性黄斑水肿神经血管耦合相关生物标志物的鉴定及机制分析
Front Mol Biosci. 2024 Sep 13;11:1332842. doi: 10.3389/fmolb.2024.1332842. eCollection 2024.
5
Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms.糖尿病视网膜病变:针对氧化还原和免疫机制的新治疗方法
Antioxidants (Basel). 2024 May 12;13(5):594. doi: 10.3390/antiox13050594.
6
The Value of White Cell Inflammatory Biomarkers as Potential Predictors for Diabetic Retinopathy in Type 2 Diabetes Mellitus (T2DM).白细胞炎症生物标志物作为2型糖尿病(T2DM)患者糖尿病视网膜病变潜在预测指标的价值
Biomedicines. 2023 Jul 26;11(8):2106. doi: 10.3390/biomedicines11082106.
代谢组学在糖尿病视网膜病变中的应用:系统评价。
Invest Ophthalmol Vis Sci. 2021 Aug 2;62(10):4. doi: 10.1167/iovs.62.10.4.
4
Aldose Reductase: a cause and a potential target for the treatment of diabetic complications.醛糖还原酶:糖尿病并发症治疗的原因和潜在靶点。
Arch Pharm Res. 2021 Jul;44(7):655-667. doi: 10.1007/s12272-021-01343-5. Epub 2021 Jul 19.
5
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.全球糖尿病视网膜病变的患病率及 2045 年预期负担的系统评价和荟萃分析。
Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.
6
Does Hyperglycemia Cause Oxidative Stress in the Diabetic Rat Retina?高血糖是否会引起糖尿病大鼠视网膜的氧化应激?
Cells. 2021 Apr 2;10(4):794. doi: 10.3390/cells10040794.
7
Energy Metabolism in the Inner Retina in Health and Glaucoma.健康与青光眼状态下视网膜内层的能量代谢
Int J Mol Sci. 2021 Apr 1;22(7):3689. doi: 10.3390/ijms22073689.
8
L-Citrulline ameliorates the attenuation of acetylcholine-induced vasodilation of retinal arterioles in diabetic rats.L-瓜氨酸可改善糖尿病大鼠中乙酰胆碱诱导的视网膜小动脉血管舒张功能的减弱。
Heliyon. 2021 Mar 21;7(3):e06532. doi: 10.1016/j.heliyon.2021.e06532. eCollection 2021 Mar.
9
Emerging Roles of Dyslipidemia and Hyperglycemia in Diabetic Retinopathy: Molecular Mechanisms and Clinical Perspectives.血脂异常和高血糖在糖尿病视网膜病变中的新作用:分子机制和临床观点。
Front Endocrinol (Lausanne). 2021 Mar 22;12:620045. doi: 10.3389/fendo.2021.620045. eCollection 2021.
10
Lipid metabolism dysregulation in diabetic retinopathy.糖尿病视网膜病变中的脂质代谢失调
J Lipid Res. 2021;62:100017. doi: 10.1194/jlr.TR120000981. Epub 2021 Jan 6.